<DOC>
	<DOCNO>NCT03103334</DOCNO>
	<brief_summary>The objective determine whether test product , Methotrexate 40 mg/mL solution injection administer subcutaneously prefilled needle-free delivery system Zeneo® , reference product , Methotrexate Biodim® 25 mg/mL , solution injection administer subcutaneously conventional syringe needle bioequivalent .</brief_summary>
	<brief_title>A Bioavailability Study Methotrexate 25 mg Administered Needle Injection Pre Filled Needle-free Device Healthy Volunteers .</brief_title>
	<detailed_description />
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Healthy subject BMI 18.5 30 kg/m2 Body mass &gt; 60 kg Nontobacco user Written consent give participation study Evidence clinically relevant oral , cardiovascular , hematologic , gastrointestinal , hepatic , renal , endocrine , pulmonary , neurologic , psychiatric skin disorder Heavy alcohol consumption regular exposure drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>